×
0 -0.00579150579150587 -0.00579150579150587 -0.0104247104247104 -0.00501930501930512 0 -0.00926640926640934 -0.00926640926640934
Stockreport

BRIEF-Amgen, CytomX therapeutics announce strategic collaboration in Immuno-Oncology [Reuters]

CYTOMX THERAPEUTICS (CTMX)  More Company Research Source: Reuters
Last cytomx therapeutics earnings: 11/7 04:57 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF BRIEF-Amgen, CytomX therapeutics announce strategic collaboration in Immuno-Oncology | Reuters Reuters Staff 2 Min Read Oct 3 (Reuters) - Amgen Inc: * Amgen and CytomX Therapeutics announce strategic collaboration in immuno-oncology * Co will lead later development and commercialization with global late-stage development costs shared between co, CytomX * Under agreement, Co, CytomX to co-develop probody T-cell engaging bispecific against EGFRXCD3 with CytomX leading early development * Under agreement, co will make upfront payment of $40 million and purchase $20 million of cytomx common stock * CytomX will be eligible to receive up to $455 million in development, regulatory and commercial milestones for EGFR program * CytomX to be able to opt into profit share in U.S., receive tiered, double-digit royalties on sales outside of U.S. for EGFR program * Under agreement, Co will also receive exclusive worldwide rights to develop and commercialize up to three additional, undisclosed target [Read more]

IMPACT SNAPSHOT EVENT TIME: CTMX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS